However, just one year ago, iX Biopharma’s share price was trading at a near-distressed level of around 1.5 cents per share.
After 11 years of listing, iX Biopharma’s share price finally recovered back to its IPO price during today’s trading session and currently has a market cap of around $438 million.
Back in July 2015, iX Biopharma was listed on the Catalist board with an IPO price of 46 cents. The IPO allowed the pharmaceutical company to raise some $30 million in proceeds.
